View Older Stories View More Recent Stories
-
PineBridge Investment Grade Preferred Securities Fund Announces Monthly Cash Distribution
-
Star Portfolio Corp. Announces Monthly Distribution for Star Yield Managers Class
-
U.S. Housing Recovery Fund Announces Monthly Cash Distribution
-
BMO Capital Weighs in on Tesaro (TSRO) Following Abstracts at AACR
-
BMO Capital Weighs in on ARIAD Pharmaceuticals (ARIA) Following Abstracts at AACR
-
Actavis (ACT) PT Raised to $373 at BMO Capital
-
Five Prime Therapeutics (FPRX) PT Raised to $31 at BMO Capital
-
BMO Capital Questions attractiveness Energizer (ENR) Batteries and Personal Care Businesses; PT to $137
-
Regulus Therapeutics (RGLS) Bullish Stance Reiterated at BMO Capital Following EASL Abstract for RG-101
-
Tetraphase Pharma (TTPH) Closes 4.95M Common Offering for Proceeds of $173.1M
-
Tetraphase Pharmaceuticals Announces Closing of Public Offering of Common Stock
-
Notable Mergers and Acquisitions 3/16: (VRX)/(SLXP) (LTM) (KKR)/(GE) (BX) (SHLM)
-
Leonard Green, TPG to Acquire Life Time Fitness (LTM) in $4B+ Deal
-
Life Time Fitness Enters Into Definitive Agreement to Be Acquired by Affiliates of Leonard Green & Partners and TPG
-
Prospects Encouraging for $870 Billion U.S. Food and Beverage Industry: BMO Economics
-
Media Advisory: BMO Capital Markets Group Head Darryl White to Speak at the National Bank Financial 2015 Canadian Financial Services Conference
-
Tetraphase Pharma (TTPH) Prices Larger 4.3M Common Offering at $35/Share
-
Chesswood Group Limited Announces Closing of $32 Million Public Offering and Concurrent $6 Million Private Placement
-
Tetraphase Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Unlikely Valeant (VRX) Will Lose Salix (SLXP) Deal - BMO Capital
-
TIM Group Announces Top Performing Brokerage Firms and Salespeople in Europe and North America
-
Mylan (MYL) Off Highs as Rumors Questioned
-
BMO Capital Downgrades Prosperity Bancshares (PB) to Market Perform
-
Essex Property Trust Prices $500 Million Senior Unsecured Notes Due April 1, 2025
-
Manulife completes Subordinated Debenture offering
-
Apple (AAPL) Watch Higher Price Could Suggest Lower Units But Better Margin - BMO Capital
-
Columbia Property Trust Announces Pricing of $350 million 4.150% Senior Notes due 2025
-
Tetraphase Pharma (TTPH) Announces 3.5M Common Offering
-
Tetraphase Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
TESARO Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option by Underwriters
-
TESARO Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option by Underwriters
-
Dividend Select 15 Corp. Completes Overnight Offering of $17,595,000
-
U.S. Vacation Homes Expected to Remain Attractive for Canadian Buyers: BMO
-
Consortium Led by Fiera Axium Infrastructure Acquires Montreal Gateway Terminals from Morgan Stanley Infrastructure Partners
-
BMO Capital Positive on Apple Watch (AAPL) But Doesn't See Event as Near-Term Catalyst
-
Manulife announces Subordinated Debenture issue
-
Infocast's Marine Terminal Finance & Investment Summit Captures World Wide Presence
-
Positive Read-Through for Gilead Sciences (GILD) from ABBV/PCYC Deal
-
AbbVie's (ABBV) Pharmacyclics (PCYC) Deal Expensive, Done Out of Weakness - BMO Capital
-
BMO Capital Reiterates Bullish Stance on Celgene (CELG) Following 'Timely' REVLIMID Review
-
Intercept Pharmaceuticals (ICPT) Bullish Stance Reiterated at BMO Capital as Competitor Data in PBC Support Role of OCA
-
BMO Capital Downgrades Tenet Healthcare (THC) to Market Perform
-
BMO Harris Bank Home Buying Report: First-Time Buyers' Budgets Increased by 24 Percent over the Past Year
-
TESARO (TSRO) Prices 3.4M Common Offering at $51/Share
-
TESARO Announces Pricing of Public Offering of Common Stock
-
Halozyme Therapeutics (HALO) PT Raised to $26 at BMO Capital
-
TESARO (TSRO) Announces $150M Common Offering
-
BMO Capital Downgrades ENSCO International Plc (ESV) to Underperform
-
BMO Capital Reiterates Bullish Take on ZIOPHARM (ZIOP) Following Meetings; Co. Considering Strategic Options as CAR-T Progresses
-
Buy TubeMogul (TUBE) on Weakness, BMO Capital Said

